Clinical Trial Update: Study of Mepolizumab Safety Syringe in Asthmatics [Phase 3]

View source ↗

Summary

Phase 3 trial update on the safety syringe of mepolizumab in asthmatics; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-01-31